Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS.

Original publication

DOI

10.1016/j.neuron.2018.02.027

Type

Journal article

Journal

Neuron

Publication Date

21/03/2018

Volume

97

Pages

1268 - 1283.e6

Keywords

ALS, GWAS, KIF5A, WES, WGS, axonal transport, cargo, Adult, Aged, Aged, 80 and over, Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Cohort Studies, Female, Genome-Wide Association Study, Humans, Kinesin, Loss of Function Mutation, Male, Middle Aged, Young Adult